GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Interpharm Holdings Inc (GREY:IPAH) » Definitions » Debt-to-Equity

Interpharm Holdings (Interpharm Holdings) Debt-to-Equity : -7.27 (As of Dec. 2007)


View and export this data going back to 2008. Start your Free Trial

What is Interpharm Holdings Debt-to-Equity?

Interpharm Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2007 was $30.68 Mil. Interpharm Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2007 was $7.79 Mil. Interpharm Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2007 was $-5.29 Mil. Interpharm Holdings's debt to equity for the quarter that ended in Dec. 2007 was -7.27.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Interpharm Holdings's Debt-to-Equity or its related term are showing as below:

IPAH's Debt-to-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

Interpharm Holdings Debt-to-Equity Historical Data

The historical data trend for Interpharm Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interpharm Holdings Debt-to-Equity Chart

Interpharm Holdings Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.34 0.74 0.69 2.33

Interpharm Holdings Quarterly Data
Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.79 2.33 6.28 -7.27

Competitive Comparison of Interpharm Holdings's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Interpharm Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interpharm Holdings's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Interpharm Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Interpharm Holdings's Debt-to-Equity falls into.



Interpharm Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Interpharm Holdings's Debt to Equity Ratio for the fiscal year that ended in Jun. 2007 is calculated as

Interpharm Holdings's Debt to Equity Ratio for the quarter that ended in Dec. 2007 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Interpharm Holdings  (GREY:IPAH) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Interpharm Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Interpharm Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Interpharm Holdings (Interpharm Holdings) Business Description

Traded in Other Exchanges
N/A
Address
75 Adams Avenue, Hauppague, NY, USA, 11788
Website
Interpharm Holdings Inc manufactures generic and over-the-counter medications. The company also pursues the development of other generic drugs in broad categories.

Interpharm Holdings (Interpharm Holdings) Headlines

No Headlines